Brian Piekos
Chief Financial Officer, AMAG Pharmaceuticals.
Companies
- KalVista Pharmaceuticals, Inc.Chief financial officer Sep 11, 2024 to now1
- Elicio Therapeutics, Inc.Chief financial officer Jun 5, 2023 to Feb 5, 20242
- Disc Medicine, Inc.Chief financial officer Feb 19, 2021 to Jun 2, 20223
- AMAG PharmaceuticalsChief financial officer Jun 19, 2020 to Nov 17, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Disc Medicine, Inc. IRON17,615 shares5$1.4M at $78.36May 31, 2022
- KalVista Pharmaceuticals, Inc.0 shares6Jun 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2026Returned to company 21,661 shares of KalVista Pharmaceuticals, Inc.6
- May 22, 2026Sold 1,489 shares at $26.78 of KalVista Pharmaceuticals, Inc.7
- May 21, 2026Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.7
- Apr 17, 2026Sold 1,862 shares at $20.22 of KalVista Pharmaceuticals, Inc.8
- Apr 16, 2026Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.8
- Feb 23, 2026Sold 1,767 shares at $15.57 of KalVista Pharmaceuticals, Inc.9
- Feb 21, 2026Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.9
- Nov 24, 2025Sold 4,471 shares at $13.45 of KalVista Pharmaceuticals, Inc.10
- Nov 21, 2025Exercised options 15,000 shares of KalVista Pharmaceuticals, Inc.10
- May 31, 2022Granted 9,960 shares at $1.09 of Disc Medicine, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed May 26, 2026
- 8SEC EDGARForm 4 filed Apr 20, 2026
- 9SEC EDGARForm 4 filed Feb 24, 2026
- 10SEC EDGARForm 4 filed Nov 26, 2025